AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

Dow Jones12-17 06:21

DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ shed 0.53% to $66.23 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.24% to 20,173.89 and the Dow Jones Industrial Average falling 0.25% to 43,717.48.

This was the ADR's third consecutive day of losses.

AstraZeneca PLC ADR closed $21.45 below its 52-week high ($87.68), which the company achieved on August 30th.

The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 1.28% to $779.00, Biogen Inc. $(BIIB)$ rose 0.31% to $150.49, and Johnson & Johnson $(JNJ)$ fell 1.89% to $143.85.

Trading volume (6.6 M) eclipsed its 50-day average volume of 5.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 16, 2024 17:21 ET (22:21 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492298406?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-17 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492298406","market":"hk","top_or_hot":-1,"title":"AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> shed 0.53% to $66.23 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.24% to 20,173.89 and the Dow Jones Industrial Average  falling 0.25% to 43,717.48. \n</p>\n<p>\n     This was the ADR's third consecutive day of losses. \n</p>\n<p>\n     AstraZeneca PLC ADR closed $21.45 below its 52-week high ($87.68), which the company achieved on August 30th. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> fell 1.28% to $779.00, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> rose 0.31% to $150.49, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> fell 1.89% to $143.85. \n</p>\n<p>\n     Trading volume (6.6 M) eclipsed its 50-day average volume of 5.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 16, 2024 17:21 ET (22:21 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 06:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZN","symbol_name":"阿斯利康","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2492298406","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492298406","pubTimestamp":1734387660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  shed 0.53% to $66.23 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.24% to 20,173.89 and the Dow Jones Industrial Average  falling 0.25% to 43,717.48.This was the ADR's third consecutive day of losses.AstraZeneca PLC ADR closed $21.45 below its 52-week high , which the company achieved on August 30th.The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co.  fell 1.28% to $779.00, Biogen Inc.  rose 0.31% to $150.49, and Johnson & Johnson  fell 1.89% to $143.85.Trading volume  eclipsed its 50-day average volume of 5.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires a","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AZN":"阿斯利康"},"translate_title":"尽管当天亏损，阿斯利康公司ADR的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1},"content_text":"DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca PLC ADR $(AZN)$ shed 0.53% to $66.23 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 1.24% to 20,173.89 and the Dow Jones Industrial Average  falling 0.25% to 43,717.48. \n\n\n     This was the ADR's third consecutive day of losses. \n\n\n     AstraZeneca PLC ADR closed $21.45 below its 52-week high ($87.68), which the company achieved on August 30th. \n\n\n     The ADR demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co. $(LLY)$ fell 1.28% to $779.00, Biogen Inc. $(BIIB)$ rose 0.31% to $150.49, and Johnson & Johnson $(JNJ)$ fell 1.89% to $143.85. \n\n\n     Trading volume (6.6 M) eclipsed its 50-day average volume of 5.8 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 16, 2024 17:21 ET (22:21 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492298406"}